Barclays’s SI-BONE Inc SIBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Sell
43,564
-58,828
-57% -$920K ﹤0.01% 3142
2025
Q4
$2.02M Buy
102,392
+10,598
+12% +$184K ﹤0.01% 2928
2025
Q3
$1.35M Sell
91,794
-12,109
-12% -$198K ﹤0.01% 3183
2025
Q2
$1.96M Buy
103,903
+32,891
+46% +$545K ﹤0.01% 2865
2025
Q1
$996K Sell
71,012
-28,200
-28% -$455K ﹤0.01% 3107
2024
Q4
$1.39M Buy
99,212
+2,589
+3% +$34.8K ﹤0.01% 3157
2024
Q3
$1.35M Buy
96,623
+63,402
+191% +$954K ﹤0.01% 3148
2024
Q2
$430K Sell
33,221
-21,332
-39% -$305K ﹤0.01% 3132
2024
Q1
$893K Sell
54,553
-26,411
-33% -$497K ﹤0.01% 3209
2023
Q4
$1.7M Buy
80,964
+56,678
+233% +$1.05M ﹤0.01% 3043
2023
Q3
$516K Buy
24,286
+9,402
+63% +$218K ﹤0.01% 2792
2023
Q2
$402K Sell
14,884
-3,695
-20% -$90.1K ﹤0.01% 2892
2023
Q1
$365K Buy
18,579
+2,974
+19% +$52.8K ﹤0.01% 3482
2022
Q4
$212K Buy
15,605
+13,842
+785% +$202K ﹤0.01% 3805
2022
Q3
$31K Sell
1,763
-1,889
-52% -$30.2K ﹤0.01% 3929
2022
Q2
$48K Sell
3,652
-3,727
-51% -$62.1K ﹤0.01% 4051
2022
Q1
$167K Sell
7,379
-34,109
-82% -$708K ﹤0.01% 3529
2021
Q4
$922K Buy
41,488
+24,616
+146% +$530K ﹤0.01% 2881
2021
Q3
$361K Buy
16,872
+7,401
+78% +$187K ﹤0.01% 3343
2021
Q2
$298K Sell
9,471
-14,679
-61% -$475K ﹤0.01% 3354
2021
Q1
$768K Buy
24,150
+14,102
+140% +$434K ﹤0.01% 2933
2020
Q4
$301K Sell
10,048
-1,554
-13% -$37.8K ﹤0.01% 3545
2020
Q3
$275K Sell
11,602
-8,277
-42% -$164K ﹤0.01% 3644
2020
Q2
$316K Buy
19,879
+8,140
+69% +$128K ﹤0.01% 3706
2020
Q1
$140K Sell
11,739
-10,613
-47% -$195K ﹤0.01% 4547
2019
Q4
$481K Buy
22,352
+3,110
+16% +$55.8K ﹤0.01% 4343
2019
Q3
$340K Sell
19,242
-1,065
-5% -$20.4K ﹤0.01% 4563
2019
Q2
$413K Buy
20,307
+2,425
+14% +$41.6K ﹤0.01% 4496
2019
Q1
$337K Buy
17,882
+17,683
+8,886% +$342K ﹤0.01% 4427
2018
Q4
$4K Buy
+199
New +$3.77K ﹤0.01% 6550

Other funds holding SIBN

Barclays's SIBN Position: Q1 2026 in Review

Barclays reduced its SI-BONE Inc (SIBN) stake by 57% in Q1 2026, selling an estimated $920K and leaving 43,564 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

Barclays first reported a position in SIBN in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.02M in Q4 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

  • Barclays held 43,564 shares of SI-BONE Inc worth $550K as of Q1 2026.
  • Barclays sold 58,828 SI-BONE Inc shares in Q1 2026, an estimated $920K.
  • SI-BONE Inc made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3142 holding.
  • Barclays first reported a position in SI-BONE Inc in Q4 2018 and has held it in 30 quarters since.
  • Barclays's SI-BONE Inc position peaked at $2.02M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.